Opportunity Information: Apply for RFA PS 16 00103CONT18
The Minority HIV/AIDS Research Initiative (MARI) continuation opportunity is a CDC cooperative agreement designed to sustain and strengthen HIV prevention, treatment, and research capacity in Black and Hispanic communities that are disproportionately affected by HIV, while also supporting the development and success of historically underrepresented researchers working in HIV. The emphasis is on building durable infrastructure and expertise that can improve HIV outcomes in communities facing persistent inequities, and on reinforcing pipelines for investigators who have historically had fewer opportunities and resources within the broader research enterprise.
This particular notice (Funding Opportunity Number RFA PS 16 00103CONT18) is not a new, open competition. It is a continuation action restricted only to organizations or entities that previously received an award under the original CDC MARI funding announcement (RFA-PS-16-001). In practical terms, that means new applicants are not eligible to apply; only prior awardees can receive continued funding under this continuation mechanism. The opportunity category is explicitly listed as "Continuation," which signals the intent to provide additional support to maintain progress on already-approved work rather than to solicit brand-new proposals from the field.
The award is administered by the Centers for Disease Control and Prevention through its ERA system, and it uses a cooperative agreement funding instrument. A cooperative agreement typically indicates that CDC expects to have substantial involvement in the funded work, such as collaborative planning, technical assistance, shared monitoring of progress, and coordination to ensure activities align with federal public health priorities. The activity category is Health, and the CFDA number is 93.941, tying the award to CDC public health assistance programming connected to HIV prevention and related capacity-building efforts.
Key programmatic themes reflected in the title and description include: expanding and sustaining community-focused HIV prevention and treatment capacity in Black and Hispanic populations; strengthening local or institutional ability to conduct high-quality HIV-related research; and developing the careers and leadership of historically underrepresented researchers so that the research workforce better reflects the communities most affected by HIV and is better positioned to ask relevant questions, build trust, and translate findings into practice. While the short description here does not list specific required activities, continuation awards generally support execution and refinement of an existing CDC-approved work plan, continuation of partnerships, ongoing evaluation, dissemination of findings, and maintenance of program infrastructure created during the initial award period.
Administrative details in the source record indicate an original closing date of 2018-01-31, a creation date of 2017-11-03, and an award ceiling listed as 0, which commonly appears in postings where funding amounts are not re-advertised publicly for a continuation action or where the ceiling is not specified in the summary record. The "ExpectedAwards" field is blank in the provided data, which is also consistent with a continuation posting where the number of awards is predetermined by the set of existing grantees rather than by a competitive selection of new applicants.
Overall, this opportunity functions as a CDC mechanism to keep previously funded MARI projects moving forward, preserving momentum in HIV prevention and treatment capacity-building in disproportionately impacted Black and Hispanic communities, and continuing to invest in the research capacity and career development of historically underrepresented investigators who are central to long-term equity-focused progress in HIV outcomes.Apply for RFA PS 16 00103CONT18
- The Centers for Disease Control and Prevention - ERA in the health sector is offering a public funding opportunity titled "Minority HIV/AIDS Research Initiative (MARI) to Build HIV Prevention, Treatment and Research Capacity in Disproportionately Affected Black and Hispanic Communities and Among Historically Underrepresented Researchers" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.941.
- This funding opportunity was created on 2017-11-03.
- Applicants must submit their applications by 2018-01-31. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same agency: Centers for Disease Control and Prevention - ERA
Browse more opportunities from the same category: Health
Next opportunity: Personalized Strategies to Manage Symptoms of Chronic Illness (R01 Clinical Trial Optional)
Previous opportunity: MIDDLE EAST/EDUCATION (ME/ED) UMBRELLA ANNUAL PROGRAM STATEMENT (APS)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA PS 16 00103CONT18
Applicants also applied for:
Applicants who have applied for this opportunity (RFA PS 16 00103CONT18) also looked into and applied for these:
| Funding Opportunity |
|---|
| Innovation Award for Mechanistic Studies to Optimize Mind and Body Interventions in NCCIH High Priority Research Topics (R33 Clinical Trial Required) Apply for PAR 18 115 Funding Number: PAR 18 115 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Emerging Infectious Sentinel Networks (EISN) Research Apply for RFA CK 16 00103CONT18 Funding Number: RFA CK 16 00103CONT18 Agency: Centers for Disease Control and Prevention - ERA Category: Health Funding Amount: Case Dependent |
| NCCIH Mind and Body Clinical Trial Cooperative Agreement (U01 Clinical Trial Required) Apply for PAR 18 118 Funding Number: PAR 18 118 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Improving Outcomes for Disorders of Human Communication (R21 Clinical Trial Optional) Apply for PA 18 288 Funding Number: PA 18 288 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Population-based HIV Impact Assessments in Resource-Constrained Settings under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH14 1409A Funding Number: CDC RFA GH14 1409A Agency: Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Human Studies to Evaluate Promising Medications to Treat Alcohol Use Disorder (R03 Clinical Trial Required) Apply for PA 18 198 Funding Number: PA 18 198 Agency: National Institutes of Health Category: Health Funding Amount: $50,000 |
| Human Studies to Evaluate Promising Medications to Treat Alcohol Use Disorder (R21 Clinical Trial Required) Apply for PA 18 197 Funding Number: PA 18 197 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Systems Biology Approaches using Non-Mammalian Laboratory Animals to Uncover Causes of Neurodegeneration that Might Underlie Alzheimers Disease and Related Dementias (R01 Clinical Trial Not Allowed) Apply for RFA AG 18 021 Funding Number: RFA AG 18 021 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Screening and Brief Alcohol Interventions in Underage and Young Adult Populations (R03 Clinical Trial Optional) Apply for PA 18 200 Funding Number: PA 18 200 Agency: National Institutes of Health Category: Health Funding Amount: $50,000 |
| Alcohol Use Disorders: Behavioral Treatment, Services and Recovery Research (R03 Clinical Trial Optional) Apply for PA 18 201 Funding Number: PA 18 201 Agency: National Institutes of Health Category: Health Funding Amount: $50,000 |
| Alcohol Use Disorders: Behavioral Treatment, Services and Recovery Research (R21 Clinical Trial Optional) Apply for PA 18 202 Funding Number: PA 18 202 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Human Studies to Evaluate Promising Medications to Treat Alcohol Use Disorder (R01 Clinical Trial Required) Apply for PA 18 192 Funding Number: PA 18 192 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Screening and Brief Alcohol Interventions in Underage and Young Adult Populations (R01 Clinical Trial Optional) Apply for PA 18 193 Funding Number: PA 18 193 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Alcohol Use Disorders: Behavioral Treatment, Services and Recovery Research (R01 Clinical Trial Optional) Apply for PA 18 194 Funding Number: PA 18 194 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Screening and Brief Alcohol Interventions in Underage and Young Adult Populations (R21 Clinical Trial Optional) Apply for PA 18 199 Funding Number: PA 18 199 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Mechanisms of Disparities for HIV- Related Co-morbidities in Health Disparity Populations (R01-Clinical Trial Not Allowed) Apply for RFA MD 18 002 Funding Number: RFA MD 18 002 Agency: National Institutes of Health Category: Health Funding Amount: $450,000 |
| NIMH Exploratory/Developmental Research Grant (R21 - Clinical Trial Not Allowed) Apply for PA 18 350 Funding Number: PA 18 350 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Selected Topics in Transfusion Medicine (R01 Clinical Trial Optional) Apply for PAR 18 126 Funding Number: PAR 18 126 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Translational Neural Devices (UG3/UH3 - Clinical Trial Required) Apply for RFA NS 18 011 Funding Number: RFA NS 18 011 Agency: National Institutes of Health Category: Health Funding Amount: $1,000,000 |
| Alzheimer's Drug-Development Program (U01 Clinical Trial Optional) Apply for PAR 18 174 Funding Number: PAR 18 174 Agency: National Institutes of Health Category: Health Funding Amount: $1,000,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA PS 16 00103CONT18", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.